Cargando…
A Systematic Review of Coronavirus Disease 2019 Vaccine Efficacy and Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Disease
Billions of doses of coronavirus disease 2019 (COVID-19) vaccines have been administered globally, dramatically reducing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) incidence and severity in some settings. Many studies suggest vaccines provide a high degree of protection against inf...
Autores principales: | Higdon, Melissa M, Wahl, Brian, Jones, Carli B, Rosen, Joseph G, Truelove, Shaun A, Baidya, Anurima, Nande, Anjalika A, ShamaeiZadeh, Parisa A, Walter, Karoline K, Feikin, Daniel R, Patel, Minal K, Deloria Knoll, Maria, Hill, Alison L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047227/ https://www.ncbi.nlm.nih.gov/pubmed/35611346 http://dx.doi.org/10.1093/ofid/ofac138 |
Ejemplares similares
-
Duration of effectiveness of vaccination against COVID-19 caused by the omicron variant
por: Higdon, Melissa M, et al.
Publicado: (2022) -
Assessing COVID-19 vaccine effectiveness against Omicron subvariants: Report from a meeting of the World Health Organization
por: Feikin, Daniel R., et al.
Publicado: (2023) -
The risk of drug resistance during long-acting antimicrobial therapy
por: Nande, Anjalika, et al.
Publicado: (2022) -
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression
por: Feikin, Daniel R, et al.
Publicado: (2022) -
Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization
por: Feikin, Daniel R., et al.
Publicado: (2022)